metricas
covid
Enfermedades Infecciosas y Microbiología Clínica (English Edition) In vitro activity of ceftobiprole and dalbavancin against a collection of coagul...
Journal Information

Statistics

Follow this link to access the full text of the article

Original article
In vitro activity of ceftobiprole and dalbavancin against a collection of coagulase-negative staphylococci isolates from clinical samples with reduced susceptibility to daptomycin and/or resistant to linezolid or glycopeptides
Evaluación de la actividad in vitro de ceftobiprol y dalbavancina frente a estafilococos coagulasa negativos con sensibilidad disminuida a daptomicina y/o resistentes a linezolid o glucopéptidos aislados de muestras clínicas
Silvia Velasco de la Fuente
Corresponding author
silviavefu@gmail.com

Corresponding author.
, Marta Fernández-Martinez, Jesús Rodríguez Lozano, Daniel Pablo-Marcos, María Siller, Jorge Calvo
Microbiology Service, University Hospital Marqués de Valdecilla – IDIVAL, Santander, Spain
Read
672
Times
was read the article
136
Total PDF
536
Total HTML
Share statistics
Article information
ISSN: 2529993X
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 15 16 31
2025 11 66 23 89
2025 10 30 6 36
2025 9 30 6 36
2025 8 53 11 64
2025 7 68 6 74
2025 6 29 1 30
2025 5 30 2 32
2025 4 21 7 28
2025 3 30 3 33
2025 2 26 4 30
2025 1 24 3 27
2024 12 20 1 21
2024 11 17 6 23
2024 10 13 5 18
2024 9 13 6 19
2024 8 10 10 20
2024 7 14 6 20
2024 6 12 5 17
2024 5 10 7 17
2024 2 1 2 3
2023 11 4 0 4
Show all

Follow this link to access the full text of the article